Showing results (61-70 of 2,447) with videos related to
Sort By:
Pageof 245
Pharmacology Research & Perspectives|August 7, 2019
Compound asset sharing initiatives between pharmaceutical companies, funding bodies, and academia: Learnings and successesAnn G Hayes, David J NuttAdvances in Alcohol & Substance Abuse|January 1, 1988
Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitorC H Gleiter, D J NuttDrug Discovery Today|May 4, 2024
Strengthening Molecular Glues: Design Strategies for Improving Thalidomide Analogs as Cereblon Effectors and Anticancer AgentsMichael J Nutt, Scott G StewartPsychiatric Services (Washington, D.C.)|July 1, 1996
Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics AnonymousK Humphreys, R H MoosPsychiatric Services (Washington, D.C.)|November 30, 2000
Assessing readmission to substance abuse treatment as an indicator of outcome and program performanceK Humphreys, K R WeingardtThe International Journal of Behavioral Nutrition and Physical Activity|June 18, 2013
Synthesising evidence for equity impacts of population-based physical activity interventions: a pilot studyDavid K Humphreys, David OgilvieInternational Journal of Epidemiology|March 1, 1991
Area variations in health outcomes: artefact or ecologyK Humphreys, R Carr-HillAmerican Journal of Community Psychology|February 1, 1997
The influence of posttreatment mutual help group participation on the friendship networks of substance abuse patientsK Humphreys, J M NokeJournal of Psychopharmacology (Oxford, England)|February 3, 2012
A cognitive dysfunction in anxiety and its amelioration by effective treatment with SSRIsA M Weinstein, D J NuttExpert Opinion on Investigational Drugs|November 4, 2000
Substance P antagonists: novel agents in the treatment of depressionS V Argyropoulos, D J NuttPageof 245